Luis M. Vilá to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Luis M. Vilá has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.561
-
Villafr?dez-D?az M, Santiago-Casas Y, Nieves-Plaza M, Morales M, Rodr?guez V, R?os G, Mart?nez D, Vil? LM. Association of the use of statins with disease activity and functional status in Puerto Ricans with rheumatoid arthritis. P R Health Sci J. 2014 Mar; 33(1):3-8.
Score: 0.396
-
Willis R, Seif AM, McGwin G, Martinez-Martinez LA, Gonz?lez EB, Doan E, Dang N, Papalardo E, Liu J, Vil? LM, Reveille JD, Alarc?n GS, Pierangeli SS. Effects of statins on proinflammatory/prothrombotic biomarkers and on disease activity scores in SLE patients: data from LUMINA (LXXVI), a multi-ethnic US cohort. Clin Exp Rheumatol. 2014 Mar-Apr; 32(2):162-7.
Score: 0.098
-
Fern?ndez M, McGwin G, Andrade R, Bastian HM, Fessler BJ, Reveille JD, Vil? LM, Alarc?n GS. Systemic lupus erythematosus in a multiethnic US cohort, LUMINA (XLIX): preliminary evaluation of the impact of statins on disease activity. J Clin Rheumatol. 2008 Jun; 14(3):178-80.
Score: 0.066